Linked Life Data

1412264

Source:http://linkedlifedata.com/resource/pubmed/id/1412264

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
19
pubmed:dateCreated
1992-11-20
pubmed:abstractText
37 diabetic children changed from insulin syringes, with individually adapted mixtures of rapid and intermediate acting insulin, to a regimen involving use of an insulin pen (Insuject, Novo Nordisk, Copenhagen) and standard insulin mixtures. During the study an attempt was made to arrive at an optimal regimen for each child by selecting from among the following available insulin preparations (proportion rapid/intermediate acting in parentheses): Velosulin (100/0), Initard (50/50), Mixtard (30/70), Combitard (15/85), and Insulatard (0/100). The 35 families who completed the one-year study maintained that the Insuject pen made the injection procedure much easier. The pen proved to motivate the children to perform the injection without help. No effort was made to increase the number of daily injections, but seven families changed from two to three daily doses on their own initiative. The HbAlc at zero, three, six, nine and 12 months were as follows (SD in parentheses): 7.5 (1.2); 7.9 (1.5); 7.6 (1.2); 7.8 (1.4); and 7.9 (2.1). We conclude that the Insuject insulin pen is a safe and reliable instrument in childhood diabetes. Good metabolic control can be obtained with commercial insulin mixtures given 2-3 times daily.
pubmed:language
nor
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0029-2001
pubmed:author
pubmed:issnType
Print
pubmed:day
20
pubmed:volume
112
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2536-7
pubmed:dateRevised
2008-7-16
pubmed:meshHeading
pubmed:year
1992
pubmed:articleTitle
[Insulin pen in the treatment of childhood diabetes].
pubmed:affiliation
Barneklinikken Haukeland sykehus, Bergen.
pubmed:publicationType
Journal Article, English Abstract